ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
PolyPid Ltd

PolyPid Ltd (PYPD)

4.60
-0.10
(-2.13%)
Closed March 29 04:00PM
4.60
0.00
(0.00%)
After Hours: 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.60
Bid
4.43
Ask
5.84
Volume
4,573
4.60 Day's Range 5.50
3.5655 52 Week Range 14.70
Market Cap
Previous Close
4.70
Open
5.16
Last Trade
2
@
5
Last Trade Time
Financial Volume
$ 24,392
VWAP
5.334
Average Volume (3m)
4,536
Shares Outstanding
1,653,559
Dividend Yield
-
PE Ratio
-0.32
Earnings Per Share (EPS)
-14.43
Revenue
-
Net Profit
-23.87M

About PolyPid Ltd

PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized ... PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Petah Tikva, Center, Isr
Founded
1970
PolyPid Ltd is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PYPD. The last closing price for PolyPid was $4.70. Over the last year, PolyPid shares have traded in a share price range of $ 3.5655 to $ 14.70.

PolyPid currently has 1,653,559 shares outstanding. The market capitalization of PolyPid is $7.61 million. PolyPid has a price to earnings ratio (PE ratio) of -0.32.

PYPD Latest News

Form S-8 - Securities to be offered to employees in employee benefit plans

As filed with the Securities and Exchange Commission on March 6, 2024 Registration No. 333-               UNITED STATES SECURITIES...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 20-F   ☐ REGISTRATION STATEMENT PURSUANTTO SECTION 12(b) OR (g) OF THE SECURITIES...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 POLYPID LTD. (Name of Issuer) Common Shares (Title of Class of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR...

Form F-3 - Registration statement by foreign private issuers

As filed with the Securities and Exchange Commission on February 1, 2024 Registration No. 333-               UNITED STATES SECURITIES...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.12.222222222224.55.54.4126464.99211294CS
4-1.18-20.41522491355.7864.4115635.16426785CS
12-2.13-31.64933135226.739.24.4145366.38266039CS
26-0.03-0.6479481641474.639.23.565555055.35844931CS
52-9.5-67.375886524814.114.73.56555724010.36490459CS
156-280.4-98.38596491232853033.565514954054.04435101CS
260-475.4-99.0416666667480583.53.565513210986.80446029CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

Your Recent History

Delayed Upgrade Clock